Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Charikleia Ntenti"'
Autor:
Androulla N. Miliotou, Sofia K. Georgiou-Siafis, Charikleia Ntenti, Ioannis S. Pappas, Lefkothea C. Papadopoulou
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 11, Pp 9181-9214 (2023)
Over 100 innovative in vitro transcribed (IVT)-mRNAs are presently undergoing clinical trials, with a projected substantial impact on the pharmaceutical market in the near future. Τhe idea behind this is that after the successful cellular internaliz
Externí odkaz:
https://doaj.org/article/547444c00cdb46749a0d9909df47308d
Autor:
Despoina Ioannidou, Evangelia S. Makri, Stergios A. Polyzos, Charikleia Ntenti, Dimitrios Agapakis, Georgios Germanidis, Antonis Goulas
Publikováno v:
Exploration of Medicine, Vol 4, Iss 1, Pp 16-22 (2023)
Aim: One single nucleotide polymorphism (SNP) rs738409 in the patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene has been considered a major genetic risk factor of nonalcoholic fatty liver disease (NAFLD). Data have indicated that N
Externí odkaz:
https://doaj.org/article/ab2b0c45edd04ae7a21515a7c07db4a8
Publikováno v:
Diagnostics, Vol 13, Iss 11, p 1915 (2023)
Medulloblastomas, highly aggressive neoplasms of the central nervous system (CNS) that present significant heterogeneity in clinical presentation, disease course, and treatment outcomes, are common in childhood. Moreover, patients who survive may be
Externí odkaz:
https://doaj.org/article/32291633b6f64c73a14c7b32e165f744
Autor:
Sofia K. Georgiou-Siafis, Androulla N. Miliotou, Charikleia Ntenti, Ioannis S. Pappas, Lefkothea C. Papadopoulou
Publikováno v:
Biomedicines, Vol 10, Iss 11, p 2885 (2022)
Chimeric antigen receptor (CAR) immunotherapy includes the genetic modification of immune cells to carry such a receptor and, thus, recognize cancer cell surface antigens. Viral transfection is currently the preferred method, but it carries the risk
Externí odkaz:
https://doaj.org/article/b66ee561b7b841cf89b0e6032177a76f
Autor:
Thomai Mouskeftara, Antonis Goulas, Despoina Ioannidou, Charikleia Ntenti, Dimitris Agapakis, Andreana Assimopoulou, Helen Gika
Publikováno v:
Metabolites, Vol 11, Iss 2, p 90 (2021)
Adiponutrin (patatin-like phospholipase domain-containing 3; PNPLA3), encoded in humans by the PNPLA3 gene, is a protein associated with lipid droplet and endoplasmic reticulum membranes, where it is apparently involved in fatty acid redistribution b
Externí odkaz:
https://doaj.org/article/95511e43b6c84e128d5a6b5f84115c6d
Autor:
Ioanna Soultati, Charikleia Ntenti, Georgia Tsaousi, Chryssa Pourzitaki, Dimitris Gkinas, Evanthia Thomaidou, Spiros Alexandrakis, Theodosios Papavramidis, Antonis Goulas
Publikováno v:
Pharmacological Reports. 75:386-396
Background Perioperative anesthetic and/or analgesic demand present considerable variation, and part of that variation appears to be genetic in origin. Here we investigate the impact of common polymorphisms in OPRM1, COMT, SLC6A4, ABCB1, and CYP2B6 g
Autor:
Natasha M. Appelman-Dijkstra, Athanasios Papatheodorou, Charikleia Ntenti, Stergios A. Polyzos, Athanasios D. Anastasilakis, Stylianos Mandanas, Polyzois Makras, Maria P. Yavropoulou
Publikováno v:
Calcified Tissue International. SPRINGER
Calcified Tissue International
Calcified Tissue International
Discontinuation of denosumab treatment is associated with rapid bone loss that could be prevented in many patients by zoledronate (ZOL) infusion given 6 months after the last denosumab injection. The effects, however, of zoledronate administration at
Autor:
Charikleia Ntenti, Polyzois Makras, Maria P. Yavropoulou, Stylianos Mandanas, Stergios A. Polyzos, Athanasios D. Anastasilakis
Publikováno v:
Endocrine. 73:223-225
Autor:
Athanasios D. Anastasilakis, Stergios Papachatzopoulos, Polyzois Makras, Athina Gkiomisi, Panagiotis Nikolakopoulos, Stergios A. Polyzos, Charikleia Ntenti, Iris Ballaouri, Spyridon Gerou, Olga Tsachouridou, Athanasios Papatheodorou, Konstantinos Aliazis, Sofia Fermanoglou, Ilias Bisbinas, Maria P. Yavropoulou
Publikováno v:
Bone. 158
GnRH-analogs induce bone loss. We aimed to investigate the effects of goserelin-induced menstrual cessation (MC) and subsequent menstrual restoration (MR) on bone metabolism (BM).In this prospective cohort study, premenopausal women (PMW) with histol
Autor:
Andrea Palermo, Maria P. Yavropoulou, Iris Ballaouri, Athanasios D. Anastasilakis, Polyzois Makras, Matthaios Savvidis, Charikleia Ntenti, Dimitrios Kitridis, Spyridon Gerou, Stergios A. Polyzos
Publikováno v:
Endocrine. 73(3)